HK1252429A1 - 自杀风险的遗传标记及相关方法 - Google Patents

自杀风险的遗传标记及相关方法 Download PDF

Info

Publication number
HK1252429A1
HK1252429A1 HK18111730.2A HK18111730A HK1252429A1 HK 1252429 A1 HK1252429 A1 HK 1252429A1 HK 18111730 A HK18111730 A HK 18111730A HK 1252429 A1 HK1252429 A1 HK 1252429A1
Authority
HK
Hong Kong
Prior art keywords
genetic markers
related methods
suicide risk
suicide
risk
Prior art date
Application number
HK18111730.2A
Other languages
English (en)
Chinese (zh)
Inventor
Clement C. Zai
James L. Kennedy
Original Assignee
Centre For Addiction And Mental Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre For Addiction And Mental Health filed Critical Centre For Addiction And Mental Health
Publication of HK1252429A1 publication Critical patent/HK1252429A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/40—Population genetics; Linkage disequilibrium
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B99/00—Subject matter not provided for in other groups of this subclass
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/30—Psychoses; Psychiatry
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Ecology (AREA)
  • Physiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK18111730.2A 2015-05-15 2015-11-19 自杀风险的遗传标记及相关方法 HK1252429A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2891830A CA2891830A1 (en) 2015-05-15 2015-05-15 Genetic markers for suicide risk and related methods
CA20152891830 2015-05-15

Publications (1)

Publication Number Publication Date
HK1252429A1 true HK1252429A1 (zh) 2019-05-24

Family

ID=57298829

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18111730.2A HK1252429A1 (zh) 2015-05-15 2015-11-19 自杀风险的遗传标记及相关方法

Country Status (7)

Country Link
US (1) US11104952B2 (https=)
EP (1) EP3294902A4 (https=)
JP (1) JP2018521629A (https=)
CA (2) CA2891830A1 (https=)
HK (1) HK1252429A1 (https=)
IL (1) IL255653A (https=)
WO (1) WO2016183659A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10395759B2 (en) 2015-05-18 2019-08-27 Regeneron Pharmaceuticals, Inc. Methods and systems for copy number variant detection
CA3014292A1 (en) 2016-02-12 2017-08-17 Regeneron Pharmaceuticals, Inc. Methods and systems for detection of abnormal karyotypes

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716810B1 (en) * 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
USH2191H1 (en) 2000-10-24 2007-06-05 Snp Consortium Identification and mapping of single nucleotide polymorphisms in the human genome
WO2004074513A1 (en) * 2003-02-21 2004-09-02 Novartis Ag Methods for the prediction of suicidality during treatment
US7361468B2 (en) 2004-07-02 2008-04-22 Affymetrix, Inc. Methods for genotyping polymorphisms in humans
WO2006102476A2 (en) * 2005-03-21 2006-09-28 Vicus Therapeutics Spe 1, Llc Compositions and methods for ameliorating cachexia
US7906283B2 (en) * 2006-10-27 2011-03-15 The United States Of America As Represented By The Department Of Health And Human Services Methods to identify patients at risk of developing adverse events during treatment with antidepressant medication
US20120094855A1 (en) * 2008-09-18 2012-04-19 Max Planck Society Means and methods for diagnosing predisposition for treatment emergent suicidal ideation (tesi)
EP2166112B1 (en) 2008-09-18 2013-06-05 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Means and methods for diagnosing predisposition for treatment emergent suicidal ideation
KR101249635B1 (ko) 2010-10-13 2013-04-01 서울대학교산학협력단 양극성 장애 진단용 ｅｇｒ2 유전자 ｓｎｐ, 그를 포함하는 마이크로어레이 및 키트
CN106062213A (zh) 2013-12-23 2016-10-26 戒毒及精神卫生中心 与自杀风险关联的遗传标志物及其使用方法

Also Published As

Publication number Publication date
IL255653A (en) 2018-01-31
EP3294902A1 (en) 2018-03-21
JP2018521629A (ja) 2018-08-09
CA2985841A1 (en) 2016-11-24
WO2016183659A1 (en) 2016-11-24
US11104952B2 (en) 2021-08-31
US20180355431A1 (en) 2018-12-13
EP3294902A4 (en) 2018-09-26
CA2891830A1 (en) 2016-11-15

Similar Documents

Publication Publication Date Title
PT3635009T (pt) Composições e métodos para internalização de enzimas
HK1257295A1 (zh) 用於免疫肿瘤学的组合物和方法
HK1254843B (zh) 包含细菌菌株的组合物
EP4582556A3 (en) Methods and compositions for whole transcriptome amplification
IL256598A (en) Malicious behavior monitoring systems and methods through multiple software entities
MX2018016038A (es) Compuestos y metodos para modular la funcion del acido ribonucleico (arn).
EP3195292A4 (en) Systems and methods for gimbal simulation
MY195720A (en) Transthyretin (Ttr) Irna Compositions and Methods of Use Thereof for Treating or Preventing Ttr-Associated Diseases
HK1216859A1 (zh) Irak抑制劑和其用途
EP3458809A4 (en) INDOOR NAVIGATION METHODS, APPARATUS AND SYSTEMS
HK1217410A1 (zh) Erk抑制劑及其用途
TW201613892A (en) Forms and compositions of an ERK inhibitor
KR101882312B1 (ko) 좌굴방지 전단형 강재댐퍼
EP3320494A4 (en) Systems and methods for predicting service time point
EP3662416A4 (en) SYSTEMS AND PROCEDURES FOR STRINGING UNITS
EP3500636A4 (en) PHOTOCHROME COMPOSITIONS, MARKERS THEREFOR AND SYSTEMS AND METHODS FOR THE USE THEREOF
HK1250145A1 (zh) 治疗多发性骨髓瘤的组合物和方法
HK1252429A1 (zh) 自杀风险的遗传标记及相关方法
EP3596082A4 (en) CDPK1 INHIBITORS, ASSOCIATED COMPOSITIONS AND PROCESSES
SG11202105238YA (en) Suicide gene
EP3665165A4 (en) DHFR INHIBITORS, ASSOCIATED COMPOSITIONS AND PROCESSES
IL258190A (en) Methods and compositions for the prevention of suicide, homicide and self-harming behaviors
WO2015175884A3 (en) Compositions and methods for treating and preventing pancreatitis, renal injury and cancer
AU2018314253B2 (en) Inline messaging
WO2014159850A3 (en) Low-phosphate repressible promoter